Synergistic Interaction of Matricaria Chamomilla Extract with Diclofenac and Indomethacin on Carrageenan‐Induced Paw Inflammation in Rats. Issue 7 (4th August 2017)

• Record Type: Journal Article
• Authors: Ortiz, Mario I.; Cariño‐Cortés, Raquel; Ponce‐Monter, Héctor A.; González‐García, Martha P.; Castañeda‐Hernández, Gilberto; Salinas‐Caballero, Mireya
• Is Part Of: Drug development research. Volume 78:Issue 7(2017)
• Page Start: 360
• Page End: 367
• Publication Date: 2017-08-04
• Subjects: non‐steroidal anti‐inflammatory drugs -- gastric damage -- Matricaria chamomilla -- inflammation -- synergism; Drug development -- Periodicals; Drugs -- Research -- Periodicals; 615.19
• DOI: 10.1002/ddr.21401
• Languages: English
• ISSNs: 0272-4391

Abstract

ABSTRACT: Preclinical Research The coadministration of non‐steroidal anti‐inflammatory drugs (NSAIDs) with medicinal plant extracts may increase anti‐inflammatory activity, thus permitting the use of lower NSAID doses and limiting the side effects. The aim of this study was to explore the interactions between an ethanolic extract of M. chamomilla extract (MCE) with two NSAIDs, diclofenac and indomethacin on carrageenan‐induced paw inflammation and gastric injury in rats. Diclofenac, indomethacin and MCE, or combinations with MCE produced an anti‐inflammatory effect. Effective dose (ED) values were estimated for the individual drugs, and isobolograms were constructed. The final experimental ED values were 483.7 mg/kg for diclofenac + MCE combination, and 212.6 mg/kg for indomethacin + MCE. These values were lower (p < 0.05) than the theoretical ED values (1186.9 mg/kg for diclofenac + MCE combination, and 1183.8 mg/kg for indomethacin + MCE). These data suggest that the interactions between NSAIDs and MCE that mediate the anti‐inflammatory effects at the systemic level are synergistic and may have therapeutic advantages for the clinical treatment of inflammatory processes. Drug Dev Res 78 : 360‐367, 2017. © 2017 Wiley Periodicals, Inc.